Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Medical Sciences Board confirms the following appointments to the position of Head of Department:

  • Professor David Paterson, Department of Physiology, Anatomy and Genetics, succeeding Professor Peter Robbins, from 1 October 2016 until 30 September 2021
  • Professor Irene Tracey, Nuffield Department of Clinical Neurosciences, succeeding Professor Christopher Kennard, from 1 October 2016 until 30 September 2021
  • Professor Nigel Emptage, Department of Pharmacology, following a period as Interim Head and in succession to Professor Antony Galione, until 30 September 2021
  • Professor Richard Hobbs, Nuffield Department of Primary Care Health Sciences (reappointment, until 30 September 2021)
  • Professor John Geddes, Department of Psychiatry (reappointment, until 30 September 2021)

Professor Alastair Buchan, Head of the Medical Sciences Division and Dean of the Medical School, commented: “I look forward to working with all the new and reappointed Heads during the next few years, and am confident that David, Irene, Nigel, Richard and John will lead their departments from strength to strength. I thank the outgoing Heads, Peter and Chris for their dedicated efforts and outstanding contributions to the University and wish them continued success.”

Related News

Irene Tracey becomes new Head of Department (Nuffield Department of Clinical Neurosciences website)

Similar stories

Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

Sensory Supermarket event helps businesses make public-facing spaces more inclusive for autistic people

Researchers from the Universities of Oxford and Reading – in collaboration with awareness-raising organisation Sensory Spectacle – are hosting an innovative event called Sensory Supermarket as part of the Sensory Street research project.

Genetic mapping of tumours reveals how cancers grow

Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.

Tackling suicide risk in people with mental disorders

Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.

Environmental impact of 57,000 multi-ingredient processed foods revealed

A study estimating the environmental impact of 57,000 food products in the UK and Ireland has been published by an Oxford-led research team in the journal PNAS.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.